Giampuzzi Monia, Oleggini Roberta, Di Donato Armando
Laboratorio di Nefrologia, Istituto G. Gaslini, Largo G. Gaslini, 5, 16147 Genova, Italy.
Biochim Biophys Acta. 2003 Apr 11;1647(1-2):239-44. doi: 10.1016/s1570-9639(03)00058-x.
Lysyl oxidase (LOX) down-regulation induced an oncogenic phenotype in NRK-49F. This event was accompanied by a constitutive activation of ras oncogene and down-regulation of PDGF beta receptor, among other important phenotypic and molecular modifications. In the present paper we show that ras activation is not accompanied by a constitutive activation of the MAP kinases as expected. Surprisingly, even if MAPK-independent, ras activation was accompanied by a constitutive Ser(63) and Ser(73) phosphorylation of c-jun, a further downstream target of ras. Although rare, this ras alternative pathway has been described. Since ras alone is seldom able to trigger cell transformation and the transformed phenotype showed clearly an abnormal adhesion pattern, we investigated the main molecules involved in cell-cell adhesion. In fact, we found that beta-catenin was up-regulated, escaping the glycogen synthase kinase-3 beta (GSK-3 beta) control, through unclear mechanisms. Its nuclear accumulation was accompanied by an up-regulation of cyclin D1, as classically described in the activation of the Wnt/beta-catenin signal pathway. We believe that the resulting up-regulation of cyclin D1 acted in synergy with ras to induce the cell transformation.
赖氨酰氧化酶(LOX)的下调在NRK - 49F细胞中诱导了致癌表型。这一事件伴随着ras癌基因的组成性激活以及血小板衍生生长因子β受体(PDGFβ受体)的下调,同时还伴有其他重要的表型和分子改变。在本文中,我们表明ras激活并未如预期那样伴随着丝裂原活化蛋白激酶(MAP激酶)的组成性激活。令人惊讶的是,即使不依赖MAPK,ras激活也伴随着c - jun的Ser(63)和Ser(73)的组成性磷酸化,c - jun是ras的一个更下游的靶点。尽管这种ras替代途径很少见,但已有相关描述。由于单独的ras很少能够触发细胞转化,并且转化后的表型明显显示出异常的黏附模式,我们研究了参与细胞间黏附的主要分子。事实上,我们发现β - 连环蛋白上调,通过不明机制逃避了糖原合酶激酶 - 3β(GSK - 3β)的调控。其核内积累伴随着细胞周期蛋白D1的上调,这与经典描述的Wnt/β - 连环蛋白信号通路激活情况一致。我们认为由此导致的细胞周期蛋白D1上调与ras协同作用诱导了细胞转化。